Invitrogen™ SARS-CoV-2 NSP7 Recombinant Protein

Catalog No.	Quantity
PIRP88284	100 μg

Catalog No. PIRP88284 Supplier Invitrogen™ Supplier No. RP88284

Description

Recombinant Protein

It is recommended that the protein be aliquoted for optimal storage. Reconstituted with sterile deionized water to 0.25mg/mL Concentration is measured by UV.

Plays a role in viral RNA synthesis (PubMed:32358203, PubMed:32277040, PubMed:32438371, PubMed:32526208). Forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers.

Specifications

• Concentration: 0.25 mg/mL
• For Use With (Application): Control, Neutralization
• Format: Lyophilized
• Formulation: 20mM tris with 0.01% mannitol, 5-8% trehalose, 0.01% Tween 80 and no preservative; pH 7.4
• Molecular Weight (g/mol): 9.4 kDa
• Name: SARS-CoV-2 NSP7
• pH Range: 7.4
• Purification Method: Purified
• Quantity: 100 μg
• Storage Requirements: -20°C, Avoid Freeze/Thaw Cycles
• Regulatory Status: RUO
• Gene Alias: COVID19 Nsp7; COVID-19 NSP7; SARS-CoV-2 Nonstructural Protein 7; SARS-CoV2 NSP7; SARS-COV-2 NSP7
• Common Name: SARS-CoV-2 NSP7
• Product Type: Protein
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Sequence: SARS-CoV-2 NSP7, amino acids Ser1-Gln83 (Accession # YP_009725303.1) with an N-terminal GP
• Content And Storage: -20°C, Avoid Freeze/Thaw Cycles
• Expression System: E. coli
• Form: Lyophilized
• Purity or Quality Grade: ≥90% as determined by SDS-PAGE.